tradingkey.logo
tradingkey.logo

Envista Holdings Corp

NVST
21.945USD
-0.055-0.25%
取引時間 ET15分遅れの株価
3.62B時価総額
233.26直近12ヶ月PER

Envista Holdings Corp

21.945
-0.055-0.25%

詳細情報 Envista Holdings Corp 企業名

Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.

Envista Holdings Corpの企業情報

企業コードNVST
会社名Envista Holdings Corp
上場日Sep 18, 2019
最高経営責任者「CEO」Keel (Paul A)
従業員数12300
証券種類Ordinary Share
決算期末Sep 18
本社所在地200 S. Kraemer Blvd., Bldg. E
都市BREA
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号92821
電話番号17148175418
ウェブサイトhttps://envistaco.com/en
企業コードNVST
上場日Sep 18, 2019
最高経営責任者「CEO」Keel (Paul A)

Envista Holdings Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
54.94K
-1.44%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+26.03%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
50.32K
-9.73%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+30.53%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+31.51%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
41.98K
-4.05%
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
33.32K
-61.88%
Mr. J. Andrew Pierce
Mr. J. Andrew Pierce
Independent Director
Independent Director
--
--
Mr. Eric D. Hammes
Mr. Eric D. Hammes
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
54.94K
-1.44%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+26.03%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
50.32K
-9.73%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+30.53%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+31.51%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
Northern America
347.90M
51.00%
Western Europe
154.10M
22.59%
Other developed markets
150.40M
22.05%
Emerging markets
29.70M
4.35%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.93%
BlackRock Institutional Trust Company, N.A.
8.71%
Ariel Investments, LLC
7.30%
Dimensional Fund Advisors, L.P.
5.80%
Franklin Mutual Advisers, LLC
5.29%
他の
62.98%
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.93%
BlackRock Institutional Trust Company, N.A.
8.71%
Ariel Investments, LLC
7.30%
Dimensional Fund Advisors, L.P.
5.80%
Franklin Mutual Advisers, LLC
5.29%
他の
62.98%
種類
株主統計
比率
Investment Advisor
53.21%
Investment Advisor/Hedge Fund
47.49%
Hedge Fund
10.48%
Research Firm
1.56%
Pension Fund
1.39%
Sovereign Wealth Fund
1.38%
Individual Investor
0.52%
Bank and Trust
0.50%
Private Equity
0.36%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
713
196.49M
119.50%
-31.47M
2025Q2
735
199.63M
120.11%
-32.52M
2025Q1
767
200.87M
118.49%
-32.33M
2024Q4
774
200.73M
116.58%
-32.33M
2024Q3
769
198.37M
115.33%
-28.47M
2024Q2
775
193.95M
112.83%
-33.23M
2024Q1
793
187.23M
108.93%
-31.14M
2023Q4
800
189.02M
110.25%
-16.86M
2023Q3
779
181.32M
105.90%
-24.06M
2023Q2
772
187.89M
114.71%
-18.52M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
16.92M
10.18%
-100.35K
-0.59%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
14.69M
8.84%
-735.51K
-4.77%
Jun 30, 2025
Ariel Investments, LLC
12.36M
7.43%
+210.92K
+1.74%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
9.17M
5.52%
+783.21K
+9.34%
Jun 30, 2025
Franklin Mutual Advisers, LLC
8.95M
5.39%
+1.28M
+16.75%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
10.81M
6.51%
-1.33M
-10.92%
Jun 30, 2025
Harris Associates L.P.
7.81M
4.7%
-869.00K
-10.01%
Jun 30, 2025
Gates Capital Management, Inc.
6.33M
3.81%
+1.16M
+22.55%
Jun 30, 2025
AllianceBernstein L.P.
6.10M
3.67%
+1.55M
+34.01%
Jun 30, 2025
Victory Capital Management Inc.
5.75M
3.46%
+313.66K
+5.77%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Tue, Dec 2
更新時刻: Tue, Dec 2
銘柄名
比率
State Street SPDR S&P Health Care Equipment ETF
1.75%
Schwab Ariel Opportunities ETF
1.51%
Pacer US Export Leaders ETF
0.88%
Distillate Small/Mid Cash Flow ETF
0.58%
Royce Quant Small-Cap Quality Value ETF
0.5%
Harbor Long-Short Equity ETF
0.45%
First Trust Health Care Alphadex Fund
0.41%
iShares U.S. Medical Devices ETF
0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
0.3%
DFA Dimensional US Small Cap Value ETF
0.27%
詳細を見る
State Street SPDR S&P Health Care Equipment ETF
比率1.75%
Schwab Ariel Opportunities ETF
比率1.51%
Pacer US Export Leaders ETF
比率0.88%
Distillate Small/Mid Cash Flow ETF
比率0.58%
Royce Quant Small-Cap Quality Value ETF
比率0.5%
Harbor Long-Short Equity ETF
比率0.45%
First Trust Health Care Alphadex Fund
比率0.41%
iShares U.S. Medical Devices ETF
比率0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
比率0.3%
DFA Dimensional US Small Cap Value ETF
比率0.27%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Envista Holdings Corpの上位5名の株主は誰ですか?

Envista Holdings Corpの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は16.92M株を保有しており、これは全体の10.18%に相当します。
BlackRock Institutional Trust Company, N.A.は14.69M株を保有しており、これは全体の8.84%に相当します。
Ariel Investments, LLCは12.36M株を保有しており、これは全体の7.43%に相当します。
Dimensional Fund Advisors, L.P.は9.17M株を保有しており、これは全体の5.52%に相当します。
Franklin Mutual Advisers, LLCは8.95M株を保有しており、これは全体の5.39%に相当します。

Envista Holdings Corpの株主タイプ上位3種は何ですか?

Envista Holdings Corpの株主タイプ上位3種は、
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Ariel Investments, LLC

Envista Holdings Corp(NVST)の株式を保有している機関の数はいくつですか?

2025Q3時点で、Envista Holdings Corpの株式を保有している機関は713社あり、保有株式の総市場価値は約196.49Mで、全体の119.50%を占めています。2025Q2と比較して、機関の持ち株は-0.62%増加しています。

Envista Holdings Corpの最大の収益源は何ですか?

FY2025Q2において、--部門がEnvista Holdings Corpにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
KeyAI